Obermatt
See Similar Stocks →

Teijin

TYO:3401 · JP3544000007
ChemicalsLarge

360

11
EV / EBIT30
Price / Owner Earnings68
Owner Earnings Yield1
Dividend Yield83
Price/Sales85
EV / Gross Profit95
Price/Book69
Return on Capital24
Cash Return on Capital8
Return on Equity8
EBIT Margin20
Gross Profitability80
Accruals100
Owner Earnings Margin16
Sales growth11
Profit Growth63
Long-Term EPS Growth6
Owner Earnings Growth1
Reinvestment78
Price momentum70
Debt load23
Refinancing78
Debt Payback1
Liquidity40
Analyst ratings7
Opinion Changes50
Price Target Upside4
Market mood79
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Teijin doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryJapan
IndustryChemicals
SizeLarge
TypePublic Company
ExchangeTSE
Founded1918
Employees249
Websiteteijin.co.jp
ISINJP3544000007
Last UpdateApr 2, 2026
Indices
Nikkei 225 (Japan)
Themes
RespiratoryBiomedical EngineeringPollution ControlCardiovascularBio-based and Renewable MaterialsUtility Scale SolarBiomass EnergyOrthopaedicsChemicalInformation TechnologyPharmaceutical

Description

Teijin Limited, through its subsidiaries, offers solutions in the areas of materials and health care. Segments The company has five industry segments: Synthetic Fibers; Films and Plastics; Pharmaceuticals and Home Health Care; Trading and Retail; a…

Analysis

Middle-of-the-road

Teijin Limited is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is tepid and the balance sheet is stretched. The company scores 4/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

What to watch: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
77
2023202420252026

All-time high

77

Jun 2026

All-time low

18

Jan 2024

Average rank

46

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
85
91
93
95
Price/Earnings
26
43
56
78
Price/Book
69
89
85
91
Dividend Yield
83
55
34
41
Value (overall)
82
75
67
81

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Teijin with its peers
HS Hyosung Advanced Materials
KSC:298050
27
CountrySouth Korea
IndustryChemicals
SizeSmall
Full Stock Analysis →
Toyobo
TYO:3101
56
CountryJapan
IndustryChemicals
SizeLarge
Full Stock Analysis →
Toray
TYO:3402
69
CountryJapan
IndustryChemicals
SizeX-Large
Full Stock Analysis →
Kuraray
TYO:3405
64
CountryJapan
IndustryChemicals
SizeX-Large
Full Stock Analysis →
Telix Pharmaceuticals
ASX:TLX
30
CountryAustralia
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Sumitomo Dainippon Pharma
TYO:4506
79
CountryJapan
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →